W. Rauschning

Long‐term outcomes following foscan®‐PDT of basal cell carcinomas

Mikhail V. Riabov, C. Hopper, C. Betz, 2012, Lasers in surgery and medicine.

Temoporfin‐mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: A multicenter study

G. Dolivet, V. Poorten, I. B. Tan, 2010, Head & neck.

Droloxifene, a new antiestrogen: Its role in metastatic breast cancer

K. Pritchard, W. Rauschning, 2004, Breast Cancer Research and Treatment.

Carboplatin. The better platinum in head and neck cancer?

E. Stennert, M. Schröder, W. Achterrath, 1989, Archives of otolaryngology--head & neck surgery.

[Results of a phase II study with the new cytostatic drug carboplatin in combination with 5-fluorouracil in the primary treatment of advanced squamous cell cancers of the head and neck].

E. Stennert, M. Schröder, W. Achterrath, 1988, HNO.

Phase II study with etoposide in previously untreated advanced breast cancer

W. Achterrath, G. Nagel, D. Meyer, 1989, Cancer Chemotherapy and Pharmacology.

Optimization of treatment parameters for Foscan®‐PDT of basal cell carcinomas

Volker Albrecht, Colin Hopper, Winrich Rauschning, 2008, Lasers in surgery and medicine.

Efficacy of low-dose mTHPC-PDT for the treatment of basal cell carcinomas

Volker Albrecht, Nikolay E. Nifantiev, Colin Hopper, 2009, World Congress of the International Photodynamic Association.

Photodynamic therapy (PDT) with mTHPC in the palliation of advanced head and neck cancer in patients who have failed prior therapies and are unsuitable for radiotherapy, surgery or systemic chemotherapy.

G. Dolivet, W. Rauschning, I. Tan, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.